⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EYPT News
EyePoint Pharmaceuticals, Inc. Common Stock
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
EYPT
EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer
globenewswire.com
EYPT
Form 8-K
sec.gov
EYPT
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
EYPT
EyePoint Announces Participation at Upcoming Investor Conferences
globenewswire.com
EYPT
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
EYPT
YUTIQ Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
globenewswire.com
EYPT
ANIP
ALOT
Form 8-K
sec.gov
EYPT
EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data
globenewswire.com
EYPT
Prevent Blindness to Host the 2026 ASPECT Patient Engagement Summit and Eyes on Capitol Hill Legislative Advocacy Day in Washington, D.C.
prnewswire.com
GILD
REGN
AMGN
JNJ
MRK
ALKS
APLS
EYPT
OCUL
VRTX